We are live on
!
Find out more
RSS
Rosenblum Silverman Sutton Portfolio holdings
AUM
$382M
1-Year Est. Return
13.82%
This Fund
S&P 500
This Quarter
Est. Return
-9.47%
1 Year Est. Return
+13.82%
3 Year Est. Return
+95.36%
5 Year Est. Return
+122.03%
10 Year Est. Return
+858.24%
AUM
$391M
AUM Growth
-$53.6M
(-12%)
Cap. Flow
-$3.31M
Cap. Flow
% of AUM
-0.85%
Top 10 Holdings %
Top 10 Hldgs %
44.66%
Holding
73
New
3
Increased
11
Reduced
40
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Generac Holdings
GNRC
|
+$5.19M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$418K |
| 3 |
iShares Core Dividend Growth ETF
DGRO
|
+$376K |
| 4 |
iShares Russell 1000 ETF
IWB
|
+$294K |
| 5 |
Vanguard Mid-Cap Growth ETF
VOT
|
+$209K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teladoc Health
TDOC
|
+$6.19M |
| 2 |
NVIDIA
NVDA
|
+$528K |
| 3 |
Natera
NTRA
|
+$343K |
| 4 |
Thermo Fisher Scientific
TMO
|
+$322K |
| 5 |
Microsoft
MSFT
|
+$315K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.12% |
| 2 | Healthcare | 14.35% |
| 3 | Consumer Discretionary | 13.48% |
| 4 | Communication Services | 10.8% |
| 5 | Financials | 10.44% |
Similar funds
STP
LWM
DSA
RC
NFP
MADR
MVP
BFP
Rosenblum Silverman Sutton's Q1 2022 Portfolio in Review
As of Q1 2022, Rosenblum Silverman Sutton held 73 positions worth $391M, down 12% from $444M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Rosenblum Silverman Sutton's Q1 2022 filing shows 3 new, 11 increased, 40 reduced and 2 closed positions. Its largest new stake was Generac Holdings: 17,312 shares worth $5.15M. The largest sale was Teladoc Health, an estimated $6.19M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Rosenblum Silverman Sutton's largest Q1 2022 buy was Generac Holdings: 17,312 shares worth $5.15M.
- Rosenblum Silverman Sutton added most to iShares Core Dividend Growth ETF in Q1 2022, an estimated $376K increase.
- Rosenblum Silverman Sutton's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $528K.
- Rosenblum Silverman Sutton fully exited Teladoc Health in Q1 2022, selling an estimated $6.19M.
- Rosenblum Silverman Sutton's ten largest holdings make up 45% of its $391M portfolio in Q1 2022.
- Rosenblum Silverman Sutton opened 3 new positions and closed 2 in Q1 2022.
- Rosenblum Silverman Sutton's portfolio value fell 12% quarter-over-quarter to $391M.
Based on Rosenblum Silverman Sutton's 13F filing for Q1 2022, filed 13 May 2022.